A nonprofit generic drug company, whose members include health systems with an Illinois presence, said Thursday it plans to manufacture and distribute insulins at “significantly lower prices” compared to what’s currently available.
Harvard researchers study COVID-19 genome to predict severity
Researchers from Harvard University studied the DNA of COVID-19 viruses taken from more than 8,000 patients in an attempt to